13F-HR filed by ACUTA CAPITAL PARTNERS, LLC
ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2020-03-31, filed 2020-05-15, with 32 holding rows worth $206,318,000.
- Accession
- 0001493152-20-009104
- Filer
- CIK 1582844
- Filed
- 2020-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2020
A holdings report, 32 entries on the cover page, a total value of $206,318,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $206,318,000 with VALUE read as thousands by filing date, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 2,673,718 | $20,949,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 308,500 | $18,149,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 1,704,500 | $16,653,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 399,500 | $11,959,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 280,120 | $11,289,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 770,000 | $11,173,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 1,070,000 | $10,679,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 2,360,000 | $9,888,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 3,720,930 | $9,496,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 628,500 | $7,127,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 63,200 | $7,117,000 | thousands by filing date | |
| BIOXCEL THERAPEUTICS INC | 09075P105 | COM | 315,000 | $7,040,000 | thousands by filing date | |
| CATALYST BIOSCIENCES INC | 14888D208 | COM | 1,384,600 | $6,051,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 2,364,204 | $5,698,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 209,500 | $5,613,000 | thousands by filing date | |
| LIFESCI ACQUISITION CORP | 53228P208 | UNIT 03/31/2025 | 560,000 | $5,599,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 827,500 | $4,824,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 256,500 | $4,712,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 139,464 | $4,383,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 56,000 | $4,032,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 23,500 | $3,392,000 | thousands by filing date | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 102,000 | $3,334,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 109,700 | $3,156,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 90,950 | $3,102,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 53,000 | $2,515,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q101 | COM | 1,038,000 | $2,107,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 39,000 | $1,993,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 198,000 | $1,970,000 | thousands by filing date | |
| ZAFGEN INC | 98885E103 | COM | 1,386,000 | $1,067,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 250,000 | $500,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 139,000 | $478,000 | thousands by filing date | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 269,907 | $273,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-20-009104 | this filing | 2020-05-15 | acceptance time not in the bulk data set |